您的位置: 首页 > 农业专利 > 详情页

EBNA1 INHIBITORS AND METHODS USING SAME
专利权人:
THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
发明人:
Troy E. Messick,Garry R. Smith,Allen B. Reitz,Paul M. Lieberman,Mark E. McDonnell,Yan Zhang,Marianne Carlsen,Shuai Chen
申请号:
US15571223
公开号:
US20180305312A1
申请日:
2016.05.14
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention provides EBNA1 inhibitors, and/or pharmaceutical compositions comprising the same, that are useful for the treatment of diseases caused by EBNA1 activity, such as, but not limited to, cancer, infectious mononucleosis, chronic fatigue syndrome, multiple sclerosis, systemic lupus erythematosus and/or rheumatoid arthritis. The present invention further provides EBNA1 inhibitors, and/or pharmaceutical compositions comprising the same, that are useful for the treatment of diseases caused by latent Epstein-Barr Virus (EBV) infection and/or lytic EBV infection.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充